Aap Implantate AG, a leading medical technology company, represents several core values and a strong corporate philosophy. The company is committed to delivering innovative solutions in the field of biomaterials, focusing on orthopaedics and trauma. With a mission to improve patients' quality of life, Aap Implantate AG prioritizes product quality, reliability, and safety. The company's philosophy revolves around continuously enhancing its product portfolio, collaborating with healthcare professionals, and promoting medical advancements. Aap Implantate AG aims to provide superior patient outcomes through its reliable and technologically advanced products, making it a trusted and respected name in the industry.

Aap Implantate AG is primarily present in Germany, its home country, where it is headquartered. The company also has a significant presence in other European countries, including Austria, Switzerland, France, and the United Kingdom. With its extensive global distribution network, Aap Implantate AG serves customers and markets worldwide.

Some significant milestones achieved by Aap Implantate AG include the successful development and commercialization of innovative medical devices for bone and joint surgeries. They have gained regulatory approvals in various countries for their products, expanding their global reach. Aap Implantate AG has also obtained ISO certification, ensuring their commitment to quality and safety standards. The company has established strategic partnerships and collaborations with renowned healthcare providers and institutions. Aap Implantate AG continues to invest in research and development, aiming to pioneer advancements in the field of orthopedics. These accomplishments highlight their dedication to improving patient outcomes and solidify their position in the market.

Aap Implantate AG is a German medical technology company that specializes in developing innovative implant systems and biomaterials for trauma, orthopedics, and dental applications. Founded in 1996, Aap Implantate has a rich history of providing high-quality medical solutions to patients worldwide. With a focus on research and development, the company has consistently introduced advanced implant systems and technologies to improve patient outcomes. Aap Implantate AG has established itself as a leading player in the medical technology industry, continuously demonstrating a commitment to innovation, quality, and patient care.

The main competitors of Aap Implantate AG in the market include Zimmer Biomet Holdings Inc., Stryker Corporation, Medtronic plc, and Johnson & Johnson. These companies operate in the medical technology industry and offer a range of products and solutions similar to Aap Implantate. Despite the competition, Aap Implantate AG distinguishes itself by delivering innovative and high-quality medical devices and services that meet the specific needs of patients and healthcare professionals. The company's focus on research and development, along with its strong market presence, positions Aap Implantate AG as a leading player in the industry.

Aap Implantate AG is primarily active in the healthcare industry. With a strong focus on medical technologies and products, Aap Implantate AG specializes in the development, production, and distribution of innovative orthopedic implants and biomaterials. By offering solutions for trauma surgery, biomaterials for bone and tissue reconstruction, and infection management, Aap Implantate AG aims to improve patient outcomes and enhance quality of life. This German-based company combines expertise, research, and state-of-the-art manufacturing capabilities to create cutting-edge medical solutions for healthcare professionals and patients worldwide.

The business model of Aap Implantate AG focuses on the development, manufacture, and distribution of medical devices and biomaterials for orthopedics and traumatology. Aap Implantate AG offers a comprehensive range of implants, such as bone plates, screws, and spinal implants, along with innovative pharmaceutical products. By leveraging its expertise in research and development, Aap Implantate AG aims to improve patient outcomes and enhance the efficiency of surgical procedures. With a commitment to quality and innovative solutions, Aap Implantate AG strives to address the complex needs of surgeons and patients worldwide, positioning itself as a leading player in the orthopedic medical device industry.

Aap Implantate P/E-luku on −15,03.

Aap Implantate KUV on 0,98.

AlleAktien Laatuscore Aap Implantate on 3/10.

odotettu Aap Implantate liikevaihto on 15,30 milj. EUR.

odotettu Aap Implantate voitto on −993 174,00 EUR.

The Aap Implantate AG is an internationally active medical technology company specializing in the development and production of implants and biomaterial-based products. Its "Trauma & Orthopedics" division includes the manufacture and sale of implants and instruments for the treatment of bone fractures and injuries in pelvic and spinal surgery, as well as endoprostheses for hip and knee joints. The "Biologics" division specializes in the development of products for tissue regeneration, particularly bone replacement materials. The company's core competency is the development and production of implants and biological products that enable better medical care for patients. A key factor of the business model is to collaborate closely with medical societies and clinics to better understand the needs of patients and medical professionals and develop tailored products based on these needs. A core element of Aap Implantate AG's business model is focusing on the development of holobasal implants, which are made from a single material and therefore have high biomechanical stability. These implants are characterized by excellent compatibility and rapid healing, which can accelerate patient rehabilitation. The company conducts intensive research and development work and continually invests in the advancement of products and technologies. As a result, Aap Implantate AG has acquired a number of patents and protective rights, securing a strong competitive position. Aap Implantate AG distributes its products worldwide through various channels, such as direct sales to clinics, sales to medical societies, sales through wholesalers, and online sales. The company places special emphasis on high quality and reliable delivery to achieve customer satisfaction and build long-term business relationships. Overall, Aap Implantate AG's business model is characterized by a strong focus on the needs of patients and medical professionals, as well as high innovation power and a strong competitive position. Through continuous development of products and technologies, as well as high customer satisfaction and reliable deliveries, the company has the opportunity to continue to grow and strengthen its position in the market.

Aap Implantate maksaa osinkoa 0 EUR, joka jaetaan erässä vuoden aikana.

Osinkoa ei voida tällä hetkellä laskea Aap Implantate:lle tai yhtiö ei maksa osinkoa.

Aap Implantate:n ISIN on DE000A3H2101.

Aap Implantate:n WKN on A3H210.

Aap Implantate:n tunnus on AAQ1.DE.

Viimeisen 12 kuukauden aikana Aap Implantate maksoi osinkoa edestä. Tämä vastaa noin osinkotuottoa. Seuraavan 12 kuukauden aikana Aap Implantate maksanee ennusteiden mukaan 0 EUR osingon.

Aap Implantate:n tämänhetkinen osinkotuotto on .

Aap Implantate maksaa osinkoa neljännesvuosittain. Osingot jaetaan kuukausina .

Aap Implantate maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Seuraavalle 12 kuukaudelle odotetaan 0 EUR suuruisia osinkoja. Tämä vastaa 0 % osinkotuottoa.

Aap Implantate kuuluu sektoriin 'Terveys'.

Saadaksesi viimeisimmän Aap Implantate osingon 11.3.2025, jonka suuruus on 0 EUR, sinun oli oltava omistanut osakkeen ennen ex-päivää, joka oli 11.3.2025.

Viimeisin osinko maksettiin 11.3.2025.

Vuonna 2024 Aap Implantate maksoi 0 EUR osinkoina.

Aap Implantate:n osingot maksetaan EURssa.